These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 492430)

  • 21. Prolonged renal survival and stunting, with protein-deficient diets in experimental uremia. Reversal of these effects by addition of essential amino acids.
    Salusky I; Kleinknecht C; Broyer M; Gubler MC
    J Lab Clin Med; 1981 Jan; 97(1):21-30. PubMed ID: 7452079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The functional activity of the portal vein as a reflection of the metabolic changes in experimental chronic kidney failure].
    Barabanova VV; Beresneva ON; Miroshnichenko EL; Kopylova OA; Timoshenko TE; Titova VA
    Fiziol Zh Im I M Sechenova; 1993 Jan; 79(1):64-72. PubMed ID: 8518851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the activity of the adrenergic and serotoninergic systems in chronic renal failure in humans and in rats with experimental uremia].
    Ksiazek A
    Pol Tyg Lek; 1978 Jun; 33(26):1045-6. PubMed ID: 212718
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbohydrate metabolism in rats with chronic uremia.
    BOUCOT NG; NURSER EK; MERRILL JP
    Am J Physiol; 1960 Apr; 198():797-9. PubMed ID: 13803197
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
    Estrada PN; Bajo MA; del Peso G; Iglesias P; Díez JJ; Fernández-Reyes MJ; Grande C; Sánchez Hernández R; Selgas R
    Nefrologia; 2006; 26(6):653-7. PubMed ID: 17227241
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
    Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
    Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin?
    Onishi S; Kawasaki T; Hamada K
    Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262
    [No Abstract]   [Full Text] [Related]  

  • 28. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
    Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental uremia. Description of a model producing varying degrees of stable uremia.
    Ormrod D; Miller T
    Nephron; 1980; 26(5):249-54. PubMed ID: 7422053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.
    Hauser AB; Azevedo IR; Gonçalves S; Stinghen A; Aita C; Pecoits-Filho R
    Blood Purif; 2010; 30(3):153-8. PubMed ID: 20861617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium metabolism in the rat with chronic renal failure.
    Kaye M
    J Lab Clin Med; 1974 Oct; 84(4):536-45. PubMed ID: 4414542
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of the normal pattern of renal choline metabolism during uremia in rats.
    Bean GH; Knight DS; Lowenstein LM
    Nephron; 1981; 28(4):204-6. PubMed ID: 7301006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prolonged uremia on insulin-like growth factor-I receptor autophosphorylation and tyrosine kinase activity in kidney and muscle.
    Tsao T; Fervenza F; Friedlaender M; Chen Y; Rabkin R
    Exp Nephrol; 2002; 10(4):285-92. PubMed ID: 12097832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia of chronic renal failure: studies of marrow regulation in the uremic sheep.
    Eschbach JW; Adamson JW; Anderson RG; Dennis MB
    Trans Am Soc Artif Intern Organs; 1972; 18(0):295-300. PubMed ID: 4681673
    [No Abstract]   [Full Text] [Related]  

  • 37. Arterial disease in chronic renal failure--an experimental study in the rabbit.
    Tvedegaard E
    Acta Pathol Microbiol Immunol Scand A; 1987; 290():1-28. PubMed ID: 3477940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
    J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and of malnutrition.
    Schmid G; Bahner U; Peschkes J; Heidland A
    Miner Electrolyte Metab; 1996; 22(1-3):115-8. PubMed ID: 8676800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic renal failure on skeletal and diaphragmatic muscle contraction.
    Tarasuik A; Heimer D; Bark H
    Am Rev Respir Dis; 1992 Dec; 146(6):1383-8. PubMed ID: 1456552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.